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Gut motility and visceral sensation are two important components of normal gastrointestinal (GI) tract
function. Disordered gut motility and sensation can cause signiﬁcant symptoms which not only pose
a health burden to patients, but may also mimic structural diseases and may generate many surgical
referrals from primary care. Unfortunately, diagnostic testing for disorders of function lags well behind
that for structural disease. In this article we review common presentations of functional disorders in
surgical clinics, and relevant testing modalities.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. GI motility disorders vs. functional GI disorders
The terminology of motility disorders can be confusing. GI
motility disorders are the diseases of GI transit and sphincteric func-
tions, which are often bona ﬁde neuromuscular diseases of the gut,
functional GI disorders (FGIDs), on the other hand, do not have any
structural or biochemical abnormality, and are often characterized
by visceral hypersensitivity. Both groups of disorders share many
of the same symptoms and may show impaired GI physiology.1,2
Motility disorders and FGIDs can affect any region of the GI tract.
In the esophagus, motility disorders include achalasia, scleroderma,
hypotensive and hypertensive lower esophageal sphincter, gastro-
esophageal reﬂux disease (GERD), diffuse esophageal spasm (DES)
and nutcracker esophagus. Functional heartburn, functional
dysphagia and functional chest pain of presumed esophageal origin
are among the FGIDs which are seen in the esophagus. In the
stomach, gastroparesis is the cardinal motility disorder, whereas
functional dyspepsia and functional nausea are the major FGIDs.
Cyclical vomiting syndrome is a poorly characterized vomiting
disorder which may pertain to either group. Gallbladder dysmotil-
ity and sphincter of Oddi dysfunction are two other important
motility disorders which are important in the surgical ﬁeld.2–4
In colon and rectum, colonic inertia and Hirschsprung’s disease
are organic motility disorders. On the other hand, irritable bowel
syndrome (IBS), functional constipation, functional diarrhea, func-
tional abdominal pain and functional proctalgia are considered
FGID. Defecation disorders, which include pelvic ﬂoor dyssynergia
and other forms of obstructed defecation, may be behavioral or
anatomic depending on the cause.2,3,5 Anal ﬁssure and solitary
rectal ulcer are diseases often associatedwith pelvic ﬂoor dyssyner-
gia or increased anal sphincter tone.6,7
Symptoms generated by the disturbance of gut transit or visceral
sensation may be seen in both FGIDs and motility disorders. For
example, patients with irritable bowel syndromemay have abdom-
inal pain and disturbed bowel habits or patients with diffuse esoph-
ageal spasm (DES) may have chest pain as well as dysphagia.8,9ciates Ltd. Published by Elsevier LtIt is important to differentiate between FGIDs andmotility disor-
ders as the diagnosis affects both treatment strategy and prognosis.
Ultimately, GI functional studies are helpful not only for diagnosis
of these disorders, but also to prevent any unnecessary surgery.
2. Why are functional studies of the GI tract important?
The diagnosis of FGID is generally based on symptom criteria.
Depending on the clinical scenario, exclusion of organic causes
with endoscopic studies and/or laboratory testing may be required.
The organic GI motility disorders will often have abnormal endo-
scopic or imaging ﬁndings.2,3,10 However, it should be noted that
normal investigations may be seen in the initial phases of organic
motility disorders. For instance, a patient with achalasia typically
presents with a dilated esophagus; however, in early stages and
in mild cases the gross abnormality cannot be detected, though
esophageal manometry is abnormal.
GI physiological studies help us to differentiate an FGID from
organic GI motility disorders.1 Esophageal and anorectal manom-
etry, esophageal pH-testing and esophageal impedance testing
are among the functional tests that can help physicians in the
management of patients with GI motility disorders. Over the last
years many of these tests have entered routine clinical practice
and the number of dedicated GI motility laboratories is growing.11
Despite this progress, GI function tests remain poorly understood
and underutilized in many cases.
3. Functional studies of the GI tract in surgical patients
3.1. Achalasia
Achalasia is a degenerative neurological disorder of the esoph-
agus which leads to loss of esophageal peristalsis and incomplete
relaxation of a frequently hypertensive lower esophageal sphincter
(LES). Barium upper GI studies, upper GI endoscopy and esophageal
manometry may be used to conﬁrm the diagnosis. Barium studyd. All rights reserved.
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is normal. Esophageal manometry is the gold standard for diag-
nosis, with detailed quantiﬁcation of esophageal peristalsis and
LES function in response to swallowing, and should be performed
in all cases. Upper GI endoscopy is necessary to rule out structural
lesions or pseudoachalasia.12
3.2. Gastroesophageal reﬂux disease (GERD)
GERD consists of erosive reﬂux and nonerosive reﬂux disease
(NERD). The diagnosis of erosive GERD is based on upper GI endos-
copy showing erosions and the stages of peptic damage in the
esophagus. As the esophageal mucosa looks normal in NERD, it
can not be easily differentiated from FGIDs. The diagnosis of NERD
is based on esophageal pH-testing with or without impedance
testing. Esophageal pH-testing records the exposure of esophagus
to acidic gastric content over a 24 h period or longer. Studies have
shown that not only the acidic content but also the reﬂux of mildly
alkaline contents may present with GERD symptoms. Esophageal
impedance testing detects bolus movement within the esophagus
including retrograde movement of the stomach contents regardless
of pH.13,14 Impedance testing is very helpful in patients with refrac-
tory GERD symptoms; however, consensus guidelines have not yet
implemented it as a routine approach in these patients.
Surgical fundoplication may be considered in individuals with
GERD with medical treatment failure, complications, or extra-
esophageal manifestations.15 Recommended Pre-operative workup
consists of upper GI endoscopy, pH-testing and esophageal
manometry. GI endoscopy and pH-testing are important to conﬁrm
the diagnosis. It is particularly important that patients have their
pH-testing performed off of any acid-suppressing therapy; other-
wise the sensitivity for conﬁrming abnormal esophageal acid expo-
sure will be reduced. Additionally GI endoscopy can detect the
complications like Barrett’s esophagus or peptic stricture. Upper
GI series may be considered but is not essential for the detection
of esophageal hernia and the length of the esophagus.14,15
There is still controversy on whether to perform esophageal
manometry before anti-reﬂux surgery or not.16,17 We think that
routine pre-operative esophageal manometry is valuable as it
may identify a subset of patients who are unsuitable for fundopli-
cation but whose symptoms may mimic poorly controlled GERD,
such as scleroderma or achalasia patients. Since manometry is typi-
cally performed immediately prior to pH-testing to identify the site
of the LES, it generally does not lengthen the amount of time to
complete pre-operative investigations. Esophageal impedance
testing is generally not required for the pre-operative evaluation
of patients with GERD. As our knowledge on non-acid reﬂux is
growing and considering patients with proton pump inhibitor
(PPI) failure, more studies are needed on the indications of anti-
reﬂux surgery in non-acid reﬂux and pre-operative impedance tes-
ting.18Other tests, such as scintigraphic gastric emptying studies,
have been proposed as being useful, but there is not enough
evidence to support this as a pre-operative test.15
Eosinophilic esophagitis (EOE) is a key alternative diagnosis
which has become more common over the past decade and can
frequently mimic GERD symptoms. Patients with EOE present
with dysphagia, heartburn/chest pain, or even food bolus obstruc-
tion and symptoms typically do not respond to PPIs. Esophageal
mucosal histology shows signiﬁcant eosinophilic inﬁltration. Treat-
ment is based for the most part on topical corticosteroids, although
dilatation is also performed when luminal diameter gets too small.
As the endoscopy may be visually normal in these patients, biopsy
is crucial in patients with esophageal symptoms especially in those
with allergic backgrounds.19 Although conventional manometric
studies have reported various results in EoE, studies with high-resolution manometry showed pan-esophageal pressurization
almost exclusively in EoE.20,21
3.3. Diffuse esophageal spasm and nutcracker esophagus
Diffuse esophageal spasm (DES) and nutcracker esophagus are
two uncommon motility disorders of the esophagus which respec-
tively present with simultaneous contractions and high-amplitude
peristalsis in the esophageal manometry. These patients may
present with esophageal symptoms including chest pain, dysphagia
or heartburn.22 DES and nutcracker esophagus are mostly managed
medically, although results are poor. In non-responders, interven-
tions like injection of botulinum toxin and surgical myotomy may
be performed.23,24
Although these diseases are rarely seen in surgical clinics, it is
important to differentiate them from other more commonly
managed surgical patients like GERD and achalasia. The mainstay
of diagnosis in DES and nutcracker esophagus is esophageal
manometry. High-resolution manometry (HRM) provides topo-
graphic features of esophageal contractility in more detail which
may prove helpful in the diagnosis, and in theory, it may estimate
the extent of myotomy in surgically treated patients.22,23
Based on impedance testing, DES patients may present with
normal or defected bolus transit. Whether the combination of
impedance testing and manometry can be used to select DES
patients for myotomy and for calculating the extent of myotomy
need further investigations.22,23
Although there are several discrepancies on the response of
these patients to surgical management, it is important to consider
GERD as the etiology of the esophageal motility disorders. Acid
reﬂux, through its inﬂammatory and irritant effects, has been
implicated in the etiology of DES or nutcracker esophagus. There-
fore, esophageal pH-testing is recommended before any surgical
intervention to rule out this possibility.22,25
3.4. Functional gallbladder and sphincter of oddi disorders
Patients with biliary-like pain as well as pancreatitis are often
seen in surgical clinics. In patients with biliary type pain without
any obvious organic cause, cholesterol microlithiasis, bilirubin gran-
ules, or functional biliary pain should be considered. Other impor-
tant differential diagnoses in these patients are motility disorders
of the biliary tractwhich can be subdivided to gallbladder dyskinesia
(GBD) and sphincter of Oddi dysfunction (SOD). GBD is diagnosed
based on a gallbladder ejection fraction less than 35% following
a contraction induced by the infusion of 10 ng/kg cholecystokinin
(CCK) over 3–10 min. In patients who are suspicious to have SOD,
sphincter of Oddi manometry (SOM) may be helpful. However,
SOM is invasive, not widely available, may cause pancreatitis, and
may or may not prove the diagnosis. Moreover, after a cholecystec-
omy, some patients may have recurrence of pre-operative symp-
toms. This phenomenon is called postcholecystectomy syndrome.
The major etiologies for postcholecystectomy syndrome (PCS) are
bile duct injury, biliary leak, biliary ﬁstula, retained or recurrent
bile duct stones and bile duct stricture. Sphincter of Oddi dysfunc-
tion should also be considered as an etiology for PCS.26–30
Duodenal-speciﬁc visceral hyperalgesia is another less recog-
nized category in patients with biliary symptoms; however, its
impact on the symptoms and the appropriate diagnostic methods
needs to be investigated.27
3.5. Chronic functional constipation
Chronic constipation has a complex pathophysiology. It can be
idiopathic (functional) or secondary. The diagnosis of idiopathic
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tion with the aim of excluding secondary causes like medications,
neurological or hormonal disorders. Primary constipation can be
subtyped into normal colonic transit, slow colonic transit, or
pelvic ﬂoor dysfunction (dyssynergia). In some cases the combi-
nation of slow colonic transit and pelvic ﬂoor dysfunction may
coexist.31,32
Evaluation of chronic constipation in adults starts with history
taking and physical examination.
In general, endoscopic imaging and blood tests are necessary in
patients older than 50 years of age and those with GI bleeding,
weight loss, anemia, family history of colon cancer or inﬂammatory
bowel disease, or recent constipationwithout a clear explanation.31
This point is not only true for constipation but also should be
considered in all patients who present with the symptoms of GI
motility disorders.
In patients without any organic cause, the next step of both
diagnostic and therapeutic value is starting the treatment. The
treatment of idiopathic constipation starts with education, dietary
changes, ﬁber supplementation, and subsequently laxatives. Enter-
okinetic medications such as prucalopride or lubiprostone may also
be tried.33
If the patient does not respond to the treatments or previous
investigations for organic causes were not performed, GI imaging
or endoscopic evaluations are recommended. These should be fol-
lowed by functional studies for differentiating normal colonic con-
stipation, slow colonic constipation or pelvic ﬂoor dysfunction. At
this phase, the functional diagnostic tests including anorectal
manometry, balloon expulsion testing, defecography and colonic
transit study are helpful.31,32
Functional studies in patients with chronic constipation usually
start with anorectal manometry and balloon expulsion tests. Both
tests should be abnormal for making the diagnosis of functional
defecation disorders. If one test is normal and the other one
abnormal, barium or magnetic resonance (MR) defecography are
recommended. These steps are important because at least 2 posi-
tive tests are needed to label a patient as an abnormal functional
defecation patient. Additionally, anorectal manometry can diag-
nose patients with Hirschsprung’s disease, although this is typically
diagnosed in childhood. Moreover, defecography can detect
anatomic abnormalities such as large rectoceles in women, or
occult rectal prolapse.31,32,34
The next step in the diagnosis of refractory patients is the
measurement of colonic transit. Colon transit is measured by
ingesting radio-opaque markers and studying the distribution of
the markers throughout the colon on abdominal x-ray after 5–
7days.31,32 This test is usually performed in patients who are candi-
dates for colectomy as the surgical treatment of chronic refractory
constipation.
Severely slow colon transit (colonic inertia) refractory to
medical management may be treated with partial colectomy or
ileorectal anastomosis.31,32 It should be noted however that colonic
and anorectal function studies must be performed without excep-
tion in these patients prior to irreversible surgical intervention.
3.6. Fecal incontinence
Structural, functional or sensory defects in the anorectal region
and altered bowel habits (particularly diarrhea) are the major
causes of fecal incontinence. Anorectal manometry is useful to
quantify sphincter pressures and sensation. Endoanal ultrasound
can localize defects which may be amenable to surgical repair.
Pudendal nerve terminal motor latency (PNTML) is a poor predictor
of function and prognosis and is generally not helpful.35–37 The
newly introduced high deﬁnition manometry system measuresanal sphincter pressure and shows puborectalis function and
sphincter defects in topographic 3-D images.36
3.7. Anal ﬁssure
Anal ﬁssure is frequently seen in surgical clinics. Patients with
anal ﬁssure may present with increased anal sphincter pressure.
Selective management of anal ﬁssure can be done based on the
ﬁndings of anorectal manometry6,38; however more studies are
needed to deﬁne the clear criteria for this approach.
3.8. Functional anorectal pain disorders
Functional anorectal pain disorders consist of chronic proc-
talgia and proctalgia fugax. Chronic proctalgia presents with
chronic or recurrent rectal pain or aching episodes which last
20 min or longer. Based on the presence or absence of puborec-
talis tenderness, chronic proctalgia can be classiﬁed to Levator
Ani Syndrome and unspeciﬁed functional anorectal pain respec-
tively. Proctalgia Fugax is deﬁned as recurrent episodes of pain
localized to the anus or lower rectum which lasts from seconds
to minutes without any anorectal pain between episodes.5,39
Anorectal pain disorders are less appreciated; however, it is esti-
mated that around 11 percent of US householder population
suffer from them.40 The diagnosis of anorectal pain disorders
is based on clinical ﬁndings and exclusion of organic causes.
Differentiating functional anorectal pain disorders and organic
causes of pelvic pain is important as the formers do not sufﬁ-
ciently respond to surgical interventions. Increased anal canal
pressure and electromyographical activities have been reported
in some of these patients, although whether the functional
parameters can predict patients’ response to the treatments
like biofeedback or the injection of the botulinium toxin needs
further investigations.39,41
3.9. Solitary rectal ulcer
Solitary rectal ulcer syndrome (SRUS) is a chronic disorder pre-
senting with single or multiple rectal ulcers. The underlying mech-
anism of SRUS is not well understood; however, rectal prolapse or
intussusception and forceful straining against a dyssynergic pelvic
ﬂoor have been proposed as the underlying mechanism of mucosal
ischemia and ulceration in these patients. The diagnosis of SURS is
based on sigmoidoscopy and rectal biopsy. Functional studies may
show dyssynergic defecation. Furthermore, they may reveal
a hypersensitive rectum with prolonged balloon expulsion time.
Manometric ﬁndings may identify patients who may respond to
biofeedback treatment.42–44
In Table 1, we summarized the functional tests which are recom-
mended for the diagnosis and pre-operative evaluation of the
patients with symptoms of GI motility disorders.
4. What are future directions in functional GI research?
Esophageal impedance testing and high-resolution manometry
testing modalities are rapidly improving and provide more data
which is less prone to artifact than previous pH and manometry
systems.13,45
A new technology in the ﬁeld of gastric and intestinal motility
disorders is the wireless motility capsule (WMC). WMC can assess
colonic, whole gut and regional gastrointestinal transit including
gastric emptying,34 but its role in the diagnosis of motility disorders
compared to currently available tests is not yet clear.
Visceral sensation is involved in the regulation of GI function
including motility. What is less appreciated in the ﬁeld of FGIDs
Table 1
Recommended functional gastrointestinal studies in patients with gastrointestinal
disorders.a
Disorder/disease Major symptoms Diagnostic/pre-operative
tests
Achalasia Dysphagia, regurgitation,
heartburn, chest pain,
aspiration
Esophageal manometry
Gastroesophageal
reﬂux disease (GERD)
Heartburn/chest pain,
dysphagia, regurgitation,
Esophageal PH/impedance
testing, esophageal
manometry
Nutcracker esohagus/
diffuse esophageal
spasm (DES)
Dysphagea, chest pain,
heartburn
Esophageal manometry,
esophageal PH/impedance
testing
Functional biliary
disorders
Biliary type pain Hepatobiliary scintigraphy,
sphincter of oddi
manometry
Chronic functional
constipation
Straining, lumpy or hard
stools, incomplete
evacuation, anorectal
obstruction, fewer than
3 defecations per week,
manual maneuver
Anorectal manometry,
balloon expulsion test,
defecography, colonic
transit study
Fecal incontinence Passage of fecal material
or ﬂatus, soiling
Anorectal manometry,
balloon expulsion test,
defecography, colonic
transit study, endoanal
ultrasound
Anal ﬁssure Pain, bleeding Anorectal manometry (?)b
Levator ani syndrome
and proctalgia fugax
Pelvic ﬂoor pain Anorectal manometry (?)c,d
Solitary rectal ulcer Pain, bleeding Anorectal manometry (?)d
“?”: Not proven yet.
a Functional tests are generally used after structural diseases have been ruled out.
b Pre-operative.
c Diagnostic.
d Predictor of response to biofeedback.
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testing which is majorly because of technical problems.46,47 This
issue is important from the medical perspective as alteration in
the visceral sensation may in part explain symptoms like heart-
burn, atypical chest pain of esophageal origin, biliary pains, consti-
pation or other GI dysmotilities.
Histological studies of the enteric nervous system and gastroin-
testinal muscles may provide novel and objective methods to clas-
sify GI motility disorders based on full-thickness biopsies of the
gut wall.48 Laparoscopic and less invasive percutaneous methods
have been described.49 However, much remains to be discovered
about the etiology of these disorders and further investigation is
required.
As the treatment options in FGID and GI motility disorders are
not deﬁnite and all patients with the same symptoms or diagnosis
do not have a unique GI physiology, stratifying patients based on
functional ﬁndings may help us to predict response to a treatment.
These would help us especially when we decide to treat a patient
with more invasive treatments, although more studies are needed
in this area.5. Conclusion
GI functional and motility disorders are common and frequently
have overlapping symptoms. Functional studies of the gastrointes-
tinal tract are extremely helpful to diagnose them correctly. In most
cases, these help the patients to understand the cause of their
symptoms, and often avoid further worry, testing and even unnec-
essary surgery. However, since these tests are less commonly used
compared to those for diagnosis of structural diseases, their use is
often not evidence-based. With reﬁnement and validation of thesemethods continue, they will likely become more widely available
and utilized in the future.
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